Craven House Capital PLC - London-based investment fund with minority shareholding in four Swedish-managed eCommerce and pharmaceutical businesses - Says its investee company Bio Vitos has received.
Craven House Capital PLC on Tuesday noted that its investee Bio Vitos Medical Ltd is set to own 88% of medical technology company Hemcheck Sweden AB, after receiving conditional approval from Nasdaq.
Craven House Capital PLC - London-based investment fund with minority shareholding in four Swedish-managed eCommerce and pharmaceutical businesses - Notes planned acquisition of investee Bio Vitos by.